Universe Historical Financial Ratios

UPC Stock

USD 0.62 0.02 3.28%

Universe Pharmaceuticals is promptly reporting on over 86 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 0.0096, PTB Ratio of 1.43 or Days Sales Outstanding of 90.28 will help investors to properly organize and evaluate Universe Pharmaceuticals financial condition quickly.

Quick Ratio Current Ratio

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.

About Universe Financial Ratios Analysis

Universe PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Universe Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Universe financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Universe Pharmaceuticals history.

Universe Pharmaceuticals Financial Ratios Chart

At present, Universe Pharmaceuticals' Days Of Inventory On Hand is projected to decrease significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 6.70, whereas Price To Sales Ratio is forecasted to decline to 1.75.

Price To Sales Ratio Dividend Yield Ptb Ratio Book Value Per Share Stock Based Compensation To Revenue Days Of Inventory On Hand

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Universe Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Universe Pharmaceuticals sales, a figure that is much harder to manipulate than other Universe Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Universe Pharmaceuticals dividend as a percentage of Universe Pharmaceuticals stock price. Universe Pharmaceuticals dividend yield is a measure of Universe Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Universe Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Stock Based Compensation To Revenue

A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.

Most ratios from Universe Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Universe Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.At present, Universe Pharmaceuticals' Days Of Inventory On Hand is projected to decrease significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 6.70, whereas Price To Sales Ratio is forecasted to decline to 1.75.

	2023	2024 (projected)
Dividend Yield	0.009169	0.009627
Price To Sales Ratio	1.84	1.75

Dividend Yield Price To Sales Ratio

Universe Pharmaceuticals fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding
Price To Sales Ratio		-0.99	1.0	-0.43	-0.87	-0.31	-0.22	0.22	-0.27	1.0	1.0	0.05	0.89	-0.93	0.22	0.98	-0.35	0.84	-0.26	-0.87	0.99	0.41	-0.93	0.29	1.0	0.33
Dividend Yield	-0.99		-0.99	0.42	0.85	0.26	0.3	-0.16	0.29	-0.99	-0.99	-0.01	-0.84	0.96	-0.12	-1.0	0.41	-0.83	0.28	0.84	-0.99	-0.33	0.95	-0.3	-1.0	-0.37
Ptb Ratio	1.0	-0.99		-0.44	-0.87	-0.29	-0.23	0.21	-0.28	1.0	1.0	0.05	0.88	-0.94	0.2	0.99	-0.35	0.85	-0.27	-0.87	0.99	0.39	-0.94	0.3	1.0	0.33
Days Sales Outstanding	-0.43	0.42	-0.44		0.66	-0.24	-0.47	0.37	0.26	-0.44	-0.43	-0.45	-0.54	0.52	-0.21	-0.46	-0.48	-0.83	0.26	0.71	-0.44	-0.25	0.51	-0.27	-0.43	0.42
Book Value Per Share	-0.87	0.85	-0.87	0.66		-0.05	-0.2	0.01	0.58	-0.87	-0.87	-0.49	-0.85	0.86	-0.17	-0.86	-0.06	-0.91	0.58	0.99	-0.9	-0.29	0.84	-0.6	-0.87	0.12
Free Cash Flow Yield	-0.31	0.26	-0.29	-0.24	-0.05		0.33	-0.46	-0.6	-0.29	-0.31	0.57	-0.4	0.01	-0.57	-0.2	0.31	-0.07	-0.61	0.04	-0.2	-0.64	0.13	0.6	-0.26	-0.4
Operating Cash Flow Per Share	-0.22	0.3	-0.23	-0.47	-0.2	0.33		-0.02	-0.29	-0.23	-0.22	0.81	0.15	0.28	0.35	-0.3	0.9	0.15	-0.3	-0.23	-0.2	0.18	0.32	0.29	-0.24	-0.82
Average Payables	0.22	-0.16	0.21	0.37	0.01	-0.46	-0.02		0.05	0.21	0.22	-0.03	0.28	0.0	0.23	0.1	-0.2	-0.08	0.06	0.02	0.17	0.24	0.11	-0.06	0.18	0.33
Capex To Depreciation	-0.27	0.29	-0.28	0.26	0.58	-0.6	-0.29	0.05		-0.28	-0.27	-0.8	-0.14	0.43	0.53	-0.32	-0.28	-0.37	1.0	0.5	-0.37	0.52	0.32	-1.0	-0.3	0.45
Pb Ratio	1.0	-0.99	1.0	-0.44	-0.87	-0.29	-0.23	0.21	-0.28		1.0	0.05	0.88	-0.94	0.2	0.99	-0.35	0.85	-0.27	-0.87	0.99	0.39	-0.94	0.3	1.0	0.33
Ev To Sales	1.0	-0.99	1.0	-0.43	-0.87	-0.31	-0.22	0.22	-0.27	1.0		0.05	0.89	-0.93	0.22	0.98	-0.35	0.84	-0.26	-0.87	0.99	0.41	-0.93	0.29	1.0	0.33
Free Cash Flow Per Share	0.05	-0.01	0.05	-0.45	-0.49	0.57	0.81	-0.03	-0.8	0.05	0.05		0.2	-0.1	-0.09	0.02	0.73	0.33	-0.8	-0.46	0.12	-0.19	0.0	0.8	0.05	-0.78
Roic	0.89	-0.84	0.88	-0.54	-0.85	-0.4	0.15	0.28	-0.14	0.88	0.89	0.2		-0.72	0.59	0.81	-0.05	0.84	-0.13	-0.89	0.86	0.7	-0.74	0.16	0.87	0.11
Inventory Turnover	-0.93	0.96	-0.94	0.52	0.86	0.01	0.28	0.0	0.43	-0.94	-0.93	-0.1	-0.72		0.07	-0.98	0.36	-0.84	0.42	0.83	-0.96	-0.13	0.97	-0.44	-0.95	-0.3
Net Income Per Share	0.22	-0.12	0.2	-0.21	-0.17	-0.57	0.35	0.23	0.53	0.2	0.22	-0.09	0.59	0.07		0.07	0.12	0.21	0.53	-0.26	0.13	0.97	-0.02	-0.52	0.18	0.05
Days Of Inventory On Hand	0.98	-1.0	0.99	-0.46	-0.86	-0.2	-0.3	0.1	-0.32	0.99	0.98	0.02	0.81	-0.98	0.07		-0.39	0.85	-0.31	-0.85	0.99	0.28	-0.97	0.34	0.99	0.35
Payables Turnover	-0.35	0.41	-0.35	-0.48	-0.06	0.31	0.9	-0.2	-0.28	-0.35	-0.35	0.73	-0.05	0.36	0.12	-0.39		0.13	-0.28	-0.11	-0.34	-0.05	0.36	0.27	-0.38	-0.96
Average Inventory	0.84	-0.83	0.85	-0.83	-0.91	-0.07	0.15	-0.08	-0.37	0.85	0.84	0.33	0.84	-0.84	0.21	0.85	0.13		-0.36	-0.95	0.84	0.33	-0.85	0.39	0.84	-0.12
Capex To Revenue	-0.26	0.28	-0.27	0.26	0.58	-0.61	-0.3	0.06	1.0	-0.27	-0.26	-0.8	-0.13	0.42	0.53	-0.31	-0.28	-0.36		0.49	-0.37	0.52	0.31	-1.0	-0.29	0.45
Cash Per Share	-0.87	0.84	-0.87	0.71	0.99	0.04	-0.23	0.02	0.5	-0.87	-0.87	-0.46	-0.89	0.83	-0.26	-0.85	-0.11	-0.95	0.49		-0.88	-0.37	0.84	-0.51	-0.87	0.15
Pocfratio	0.99	-0.99	0.99	-0.44	-0.9	-0.2	-0.2	0.17	-0.37	0.99	0.99	0.12	0.86	-0.96	0.13	0.99	-0.34	0.84	-0.37	-0.88		0.32	-0.94	0.39	1.0	0.3
Interest Coverage	0.41	-0.33	0.39	-0.25	-0.29	-0.64	0.18	0.24	0.52	0.39	0.41	-0.19	0.7	-0.13	0.97	0.28	-0.05	0.33	0.52	-0.37	0.32		-0.22	-0.51	0.37	0.21
Payout Ratio	-0.93	0.95	-0.94	0.51	0.84	0.13	0.32	0.11	0.32	-0.94	-0.93	0.0	-0.74	0.97	-0.02	-0.97	0.36	-0.85	0.31	0.84	-0.94	-0.22		-0.34	-0.94	-0.28
Capex To Operating Cash Flow	0.29	-0.3	0.3	-0.27	-0.6	0.6	0.29	-0.06	-1.0	0.3	0.29	0.8	0.16	-0.44	-0.52	0.34	0.27	0.39	-1.0	-0.51	0.39	-0.51	-0.34		0.32	-0.44
Pfcf Ratio	1.0	-1.0	1.0	-0.43	-0.87	-0.26	-0.24	0.18	-0.3	1.0	1.0	0.05	0.87	-0.95	0.18	0.99	-0.38	0.84	-0.29	-0.87	1.0	0.37	-0.94	0.32		0.35
Days Payables Outstanding	0.33	-0.37	0.33	0.42	0.12	-0.4	-0.82	0.33	0.45	0.33	0.33	-0.78	0.11	-0.3	0.05	0.35	-0.96	-0.12	0.45	0.15	0.3	0.21	-0.28	-0.44	0.35

Click cells to compare fundamentals

Universe Pharmaceuticals Account Relationship Matchups

Universe Pharmaceuticals fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	51.17	16.79	4.59	1.6	1.84	1.75
Ptb Ratio	75.52	13.67	3.97	1.31	1.5	1.43
Days Sales Outstanding	129.24	120.27	138.06	121.21	109.09	90.28
Book Value Per Share	5.66	16.26	12.81	10.91	9.82	6.59
Free Cash Flow Yield	0.003859	(0.0193)	(0.007628)	0.0208	0.0187	0.0197
Operating Cash Flow Per Share	1.66	(0.57)	(0.36)	0.31	0.36	0.34
Capex To Depreciation	0.13	30.28	0.18	0.0868	0.0781	0.0742
Pb Ratio	75.52	13.67	3.97	1.31	1.5	1.43
Ev To Sales	50.93	16.72	4.55	1.6	1.85	1.75
Free Cash Flow Per Share	1.65	(4.3)	(0.39)	0.3	0.34	0.19
Roic	0.51	0.33	0.18	(0.15)	(0.13)	(0.14)
Inventory Turnover	8.71	9.2	8.27	6.58	5.92	5.62
Net Income Per Share	2.06	3.12	(2.41)	(1.7)	(1.96)	(1.86)
Days Of Inventory On Hand	41.89	39.67	44.13	55.48	63.81	78.01
Payables Turnover	6.17	4.27	5.93	4.8	5.52	6.7
Sales General And Administrative To Revenue	0.0404	0.0687	0.0437	0.0686	0.0618	0.0357
Research And Ddevelopement To Revenue	0.019	0.11	0.19	0.15	0.14	0.0694
Capex To Revenue	0.001687	0.28	0.002334	0.001367	0.00123	0.001169
Cash Per Share	2.74	6.01	5.2	5.1	4.59	2.7
Pocfratio	256.91	(391.97)	(140.46)	46.12	53.04	50.38
Interest Coverage	82.84	133.76	(43.22)	(22.49)	(25.87)	(24.57)
Capex To Operating Cash Flow	0.00847	(6.58)	(0.0714)	0.0394	0.0454	0.0476
Pfcf Ratio	259.11	(51.7)	(131.1)	48.01	55.21	52.45
Days Payables Outstanding	59.14	85.56	61.5	76.1	68.49	51.86
Income Quality	1.75	0.81	(0.18)	0.15	(0.21)	(0.2)
Roe	0.36	0.19	(0.19)	(0.16)	(0.18)	(0.17)
Ev To Operating Cash Flow	255.7	(390.15)	(139.11)	46.29	53.24	50.58
Pe Ratio	207.86	71.19	(21.1)	(8.38)	(9.64)	(9.16)
Return On Tangible Assets	0.43	0.26	0.16	(0.15)	(0.12)	(0.13)
Ev To Free Cash Flow	257.89	(51.46)	(129.84)	48.19	55.42	52.65
Earnings Yield	0.004811	0.014	(0.0474)	(0.12)	(0.14)	(0.13)
Intangibles To Total Assets	0.006068	0.002544	0.002644	0.002788	0.003207	0.005537
Net Debt To E B I T D A	(0.7)	(0.26)	0.24	(0.0613)	(0.0552)	(0.058)
Current Ratio	2.91	4.5	3.17	2.68	2.41	2.22
Tangible Book Value Per Share	5.61	16.21	12.77	10.86	9.78	6.56
Receivables Turnover	2.82	3.03	2.64	3.01	3.46	3.74
Graham Number	16.18	33.8	26.36	20.42	18.38	14.82
Shareholders Equity Per Share	5.66	16.26	12.81	10.91	9.82	6.59
Debt To Equity	0.13	0.0735	0.0848	0.14	0.16	0.17
Capex Per Share	0.0141	3.73	0.0258	0.0122	0.011	0.0104

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:

How To Invest In Universe

Details

Is Universe Stock a good investment?

Details

What is Universe Pharmaceuticals' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.82)

Earnings Share

(76.35)

Revenue Per Share

7.351

Quarterly Revenue Growth

(0.30)

Return On Assets

(0.06)

The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Universe Historical Financial Ratios

About Universe Financial Ratios Analysis

Universe Pharmaceuticals Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Book Value Per Share

Stock Based Compensation To Revenue

Universe Pharmaceuticals fundamentals Correlations

Universe Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Universe Pharmaceuticals fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ptb Ratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Price To Sales Ratio
Ev To Sales	+ 1.0	Price To Sales Ratio
Pfcf Ratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 1.0	Ptb Ratio

Capex To Operating Cash Flow	- 1.0	Capex To Revenue
Capex To Operating Cash Flow	- 1.0	Capex To Depreciation
Pfcf Ratio	- 1.0	Dividend Yield
Days Of Inventory On Hand	- 1.0	Dividend Yield
Pocfratio	- 0.99	Dividend Yield
Ev To Sales	- 0.99	Dividend Yield